Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.

about

Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.

Item

http://www.wikidata.org/entity/Q39041693

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.

@en

Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.

@nl

type

Item

label

Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.

@en

Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.

@nl

prefLabel

Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.

@en

Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.

@nl

P1476

Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.

@en

P2093

Aparecida Machado de Moraes

http://www.w3.org/2001/XMLSchema#string

Carmen Silvia Passos Lima

http://www.w3.org/2001/XMLSchema#string

Cristiane Oliveira

http://www.w3.org/2001/XMLSchema#string

Gustavo Jacob Lourenço

http://www.w3.org/2001/XMLSchema#string

José Augusto Rinck-Junior

http://www.w3.org/2001/XMLSchema#string

P2860

Time course and pattern of metastasis of cutaneous melanoma differ between men and women

Epigenetic regulation in human melanoma: past and future

The Validity and Practicality of Sun-Reactive Skin Types I Through VI

Final version of 2009 AJCC melanoma staging and classification

Tamoxifen vs. non-tamoxifen treatment for advanced melanoma: a meta-analysis.

TP53 mutations in human cancers: origins, consequences, and clinical use

The p53-Mdm2 module and the ubiquitin system.

Apoptotic cell signaling in cancer progression and therapy

BCL2 family in DNA damage and cell cycle control.

p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

P2888

s12032-016-0868-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-016-0868-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28050764

http://www.w3.org/2001/XMLSchema#string